Homocysteine Inhibits Angiogenesis in Vitro and in Vivo

• Published in: Biochemical and biophysical research communications 2001-03, Vol.281 (3), p.726-731
• Main Authors: Nagai, Yoshitaka, Tasaki, Hiromi, Takatsu, Hiroyuki, Nihei, Shun-ichi, Yamashita, Kazuhito, Toyokawa, Tsuyoshi, Nakashima, Yasuhide
• Format: Article
• Language: English
• Subjects: angiogenesis; Animals; Cattle; Cell Division - drug effects; Cell Movement - drug effects; Cells, Cultured; endothelial cells; Endothelium, Vascular - cytology; Endothelium, Vascular - drug effects; homocysteine; Homocysteine - pharmacology; In Vitro Techniques; Neovascularization, Physiologic - drug effects
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1006/bbrc.2001.4400

Homocysteine has been reported to inhibit endothelial cell proliferation, which is closely related to angiogenesis. However, the relationship between homocysteine and angiogenesis is unknown. To clarify whether homocysteine would inhibit angiogenesis in vitro and in vivo, we examined the effect of homocysteine on tube formation by bovine aortic endothelial cells (BAECs) and by human microvessel endothelial cell-1 (HMEC-1) in vitro, and on angiogenesis in vivo using the chorioallantoic membrane (CAM) assay, as well as on BAEC proliferation and migration. Homocysteine, but not cysteine, inhibited BAEC proliferation, migration, and tube formation in a dose-dependent manner at concentrations from 0 to 10 mM. Homocysteine also inhibited tube formation by HMEC-1s. In these assay, 50% inhibition was induced by about 1 mM homocysteine. In the in vivo CAM assay, 0, 10, 100, 500, and 1000 μg homocysteine induced an avascular zone by 0, 0, 16.7, 53.3 and 76.5%, respectively, also showing a dose-dependent effect. It was suggested that homocysteine inhibited angiogenesis by preventing proliferation and migration of endothelial cells.